Biomea Fusion, Inc. (BMEA) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Biomea Fusion, Inc. (BMEA).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $1.67

Daily Change: +$0.08 / 4.79%

Daily Range: $1.58 - $1.70

Market Cap: $92,946,352

Daily Volume: 1,379,736

Performance Metrics

1 Week: -1.81%

1 Month: -16.41%

3 Months: -4.12%

6 Months: -60.82%

1 Year: -71.25%

YTD: -57.99%

Company Details

Employees: 106

Sector: Health technology

Industry: Pharmaceuticals: major

Country:

Details

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral covalent small molecule drugs to treat patients with metabolic diseases in the United States. It's lead product candidate icovamenib, an orally bioavailable, potent, and covalent inhibitor of menin, a ubiquitously expressed scaffold protein that functions in histone modification and epigenetic gene regulation to impact multiple cellular processes including cell cycle control, apoptosis, and DNA damage repair. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in San Carlos, California.

Selected stocks

loanDepot, Inc. (LDI)

Largo Inc. (LGO)

SmartRent, Inc. (SMRT)